Skip to main content

Table 2 Demographic description of datasets

From: A comparison of predictors for mortality and bacteraemia in patients suspected of infection

  SLB HvH TREAT04 Overall
Patients, n 199 263 1354 1816
Female, n/N (%) 90/199 (45.2) 142/263 (54.0) 658/1328 (49.5) 890/1790 (49.7)
Age, median [IQR] 67 [49–79] 75 [58–84] 72 [56–81] 72 [55–81]
Place of acquisition, n (%)
 Community 184 (93.9) 250 (95.1) 1354 (100) 1788 (98.4)
 Nursing home 12 (6.1) 11 (4.2) 0 (0) 23 (1.3)
 Hospital 0 (0) 2 (0.8) 0 (0) 2 (0.1)
Final diagnosis, n (%)
 Urinary tract infection 34 (17.1) 38 (14.6) 249 (18.4) 321 (17.7)
 Pneumonia/LRT 33 (16.6) 158 (60.5) 295 (21.8) 486 (26.8)
 Skin/soft tissue infection 14 (7.0) 10 (3.8) 149 (11.0) 173 (9.5)
 Abdominal infection 30 (15.1) 0 (0) 84 (6.2) 114 (6.3)
 Other infection 31 (15.6) 8 (3.1) 381 (28.1) 420 (23.1)
 Non-infectious 57 (28.6) 49 (18.6) 196 (14.5) 302 (16.6)
Outcomes, n (%)
 Positive blood culture
  Bacteraemia 13 (6.5) 18 (6.8) 126 (9.3) 157 (8.7)
  Contaminant 15 (7.5) 5 (1.9) 65 (4.8) 85 (4.7)
 30-day mortality 13 (6.5) 23 (8.7) 155 (11.4) 191 (10.5)